Aleniglipron
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Gasherbrum Bio, Inc · Phase 3 · Recruiting · Enrollment 3600
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| aleniglipron Arm 1 | n/r | n/r | n/r | n/r | n/r |
| aleniglipron Arm 2 | n/r | n/r | n/r | n/r | n/r |
| aleniglipron Arm 3 | n/r | n/r | n/r | n/r | n/r |
| Placebo Arm 4 | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.